Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
Sunnybrook Health Science Centre · Health Sciences Centre · +3 more institutions
Abstract
The blood-brain barrier (BBB) has long limited therapeutic access to brain tumor and peritumoral tissue. In animals, MR-guided focused ultrasound (MRgFUS) with intravenously injected microbubbles can temporarily and repeatedly disrupt the BBB in a targeted fashion, without open surgery. Our objective is to demonstrate safety and feasibility of MRgFUS BBB opening with systemically administered chemotherapy in patients with glioma in a phase I, single-arm, open-label study. Five patients with previously confirmed or suspected high-grade glioma based on imaging underwent the MRgFUS in conjunction with administration of chemotherapy (n = 1 liposomal doxorubicin, n = 4 temozolomide) one day prior to their scheduled…
Citation impact
- FWCI
- 30.79
- Percentile
- 100%
- References
- 22
Authors
12- TGTodd G. MainprizeCorresponding
Sunnybrook Health Science Centre, Health Sciences Centre
- NLNir Lipsman
Sunnybrook Health Science Centre, Health Sciences Centre, Sunnybrook Research Institute
- YHYuexi Huang
Sunnybrook Health Science Centre, Health Sciences Centre, Sunnybrook Research Institute
- YMYing Meng
Sunnybrook Health Science Centre, Health Sciences Centre, Sunnybrook Research Institute
- ABAllison Bethune
Sunnybrook Health Science Centre, Sunnybrook Research Institute
Topics & keywords
- Medicine
- Microbubbles
- Temozolomide
- Glioma
- Chemotherapy
- Blood–brain barrier
- Doxorubicin
- Adverse effect
- Good health and well-being